Frankfurt - Delayed Quote • EUR
Veracyte, Inc. (12V.F)
At close: April 26 at 8:01 AM GMT+2
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 9 | 9 |
Avg. Estimate | -0.19 | -0.14 | -1.1 | -0.51 |
Low Estimate | -0.25 | -0.2 | -1.31 | -0.78 |
High Estimate | -0.08 | -0.06 | -0.9 | -0.21 |
Year Ago EPS | -0.08 | -0.14 | -0.66 | -1.1 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 9 |
Avg. Estimate | 53.64M | 60.05M | 203.76M | 262.86M |
Low Estimate | 51.16M | 56.98M | 197.06M | 245.2M |
High Estimate | 55.39M | 64.3M | 210.42M | 290.07M |
Year Ago Sales | -- | 34.54M | 117.48M | 203.76M |
Sales Growth (year/est) | -- | 73.90% | 73.40% | 29.00% |
Earnings History
CURRENCY IN USD | 9/30/2020 | 12/31/2020 | 3/31/2021 | 6/30/2021 |
---|---|---|---|---|
EPS Est. | -0.21 | -0.11 | -0.12 | -0.25 |
EPS Actual | -0.08 | -0.14 | -0.66 | -0.13 |
Difference | 0.13 | -0.03 | -0.54 | 0.12 |
Surprise % | 61.90% | -27.30% | -450.00% | 48.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Current Estimate | -0.19 | -0.14 | -1.1 | -0.51 |
7 Days Ago | -0.19 | -0.14 | -1.1 | -0.51 |
30 Days Ago | -0.19 | -0.14 | -1.1 | -0.51 |
60 Days Ago | -0.23 | -0.17 | -1.27 | -0.64 |
90 Days Ago | -0.23 | -0.17 | -1.27 | -0.64 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | 12V.F | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -137.50% | -- | -- | 6.50% |
Next Qtr. | 0.00% | -- | -- | 12.00% |
Current Year | -66.70% | -- | -- | 5.30% |
Next Year | 53.60% | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Goldman Sachs: Buy to Buy | 4/15/2024 |
Maintains | Morgan Stanley: Underweight to Underweight | 2/26/2024 |
Maintains | Needham: Buy to Buy | 2/23/2024 |
Maintains | Morgan Stanley: Underweight to Underweight | 11/10/2023 |
Maintains | Needham: Buy to Buy | 11/8/2023 |
Maintains | Goldman Sachs: Buy to Buy | 10/23/2023 |